company

Media Coverage

Interview at T-Gen Laboratories
March, 2008>>

ImmuneRegen Receives Coverage on Local Phoenix Telecast
Sept. 3, 2007

Hollis-Eden Down On HHS Rejection of Radiation Drug
BioWorld Today
March 9, 2007

Drug Maker, Singapore Join For Study
The Business Journal
March 9, 2007

ImmuneRegen 'ripe' for a takeout; interested in ideas from bankers, CEO says
MergerMarket
March 7, 2007

Drug firm given shot in arm
Arizona Republic
Jan. 9, 2007

Firm to tap into new biodefense agency
Arizona Republic
Jan. 9, 2007

 

General Inquiries:
info@immuneregen.com

Media Coverage:
Amendola Communications
Jan Shulman
Executive Vice President
480.664.8412, ext. 12
JShulman@acmarketingpr.com

Investor Relations:

Tony Schor or Lindsay Kenoe
Investor Awareness, Inc.
847-945-2222
www.investorawareness.com
investors@immuneregen.com

Copyright © 2003-2008, ImmuneRegen Biosciences, Inc. All rights reserved.


immuneregen
ImmuneRegen's corporate offices are located at:

8767 E. Via De Ventura,
Suite 190
Scottsdale, AZ 85258

80.922.3926 - Office
480.922.4781 - Fax
866.922.3926 - Toll Free